Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical trial of SENTI-202 maintaining remission - - Strengthened ...

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...

The revelation was made by the prosecutor from the office of the Director of Public Prosecutions (DPP) when the case was called in the Westmoreland Circuit ... that the cell in which the attack ...